Avm Biotechnology Is A Clinical Stage Biotechnology Company Based In Seattlewashingtonfounded In 2008The Company Is Focused On Developing Innovative Treatments That Utilize The Body S Immune Response To Address Diseases Such As Cancerautoimmune Disordersand Infectious Diseasesled By Drtheresa Deisherwho Has A Strong Background In The Biotech Industryavm Biotechnology Is Supported By A Team Of Experts In Various Fieldsincluding Respiratory Illness And Vaccine Development The Company S Lead Productavm0703Is A Proprietary Formulation Of Dexamethasone Designed To Activate The Immune Response At High Doses Without The Use Of Benzyl Alcohol And Parabensthis Formulation Is Currently Being Tested In Fda Approved Clinical Trials For Conditions Like Lymphomaleukemiaand Acute Respiratory Distress Syndromeardsrelated To Influenza Or Covid 19Avm Biotechnology Has Also Received Funding And Holds Multiple Patents Related To Its Innovative Treatmentspositioning It As A Key Player In The Healthcare Sector
